Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncology Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Biosimilarsmarket, defines the market attractiveness level of Oncology Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology Biosimilars industry, describes the types of Oncology Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Biosimilars market and the development prospects and opportunities of Oncology Biosimilars industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Biosimilars market in Chapter 13.
By Player:
Dr Reddy’s Laboratories
Pfizer
Celltrion
BIOCAD
Intas Pharmaceuticals
STADA Arzneimittel AG
Sandoz International
Teva Pharmaceutical Industries Ltd
Apotex
Biocon
By Type:
mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others
By End-User:
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology Biosimilars Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology Biosimilars Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology Biosimilars Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology Biosimilars Market Analysis and Outlook to 2022
-
7.1 Global Oncology Biosimilars Consumption (2017-2022)
-
7.2 United States Oncology Biosimilars Consumption (2017-2022)
-
7.3 Europe Oncology Biosimilars Consumption (2017-2022)
-
7.4 China Oncology Biosimilars Consumption (2017-2022)
-
7.5 Japan Oncology Biosimilars Consumption (2017-2022)
-
7.6 India Oncology Biosimilars Consumption (2017-2022)
-
7.7 South Korea Oncology Biosimilars Consumption (2017-2022)
8 Region and Country-wise Oncology Biosimilars Market Analysis and Outlook to 2028
-
8.1 Global Oncology Biosimilars Consumption Forecast (2022-2028)
-
8.2 United States Oncology Biosimilars Consumption Forecast (2022-2028)
-
8.3 Europe Oncology Biosimilars Consumption Forecast (2022-2028)
-
8.4 China Oncology Biosimilars Consumption Forecast (2022-2028)
-
8.5 Japan Oncology Biosimilars Consumption Forecast (2022-2028)
-
8.6 India Oncology Biosimilars Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology Biosimilars Consumption Forecast (2022-2028)
9 Global Oncology Biosimilars Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Biosimilars Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global mAb Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hematopoietic Agents Consumption and Growth Rate (2017-2022)
-
9.1.4 Global G-CSF Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Biosimilars Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Oncology Biosimilars Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global mAb Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hematopoietic Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global G-CSF Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology Biosimilars Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology Biosimilars Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology Biosimilars Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology Biosimilars Market Competitive Analysis
-
14.1 Dr Reddy’s Laboratories
-
14.1.1 Dr Reddy’s Laboratories Company Details
-
14.1.2 Dr Reddy’s Laboratories Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dr Reddy’s Laboratories Oncology Biosimilars Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Oncology Biosimilars Product and Service
-
14.3 Celltrion
-
14.3.1 Celltrion Company Details
-
14.3.2 Celltrion Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celltrion Oncology Biosimilars Product and Service
-
14.4 BIOCAD
-
14.4.1 BIOCAD Company Details
-
14.4.2 BIOCAD Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 BIOCAD Oncology Biosimilars Product and Service
-
14.5 Intas Pharmaceuticals
-
14.5.1 Intas Pharmaceuticals Company Details
-
14.5.2 Intas Pharmaceuticals Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Intas Pharmaceuticals Oncology Biosimilars Product and Service
-
14.6 STADA Arzneimittel AG
-
14.6.1 STADA Arzneimittel AG Company Details
-
14.6.2 STADA Arzneimittel AG Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 STADA Arzneimittel AG Oncology Biosimilars Product and Service
-
14.7 Sandoz International
-
14.7.1 Sandoz International Company Details
-
14.7.2 Sandoz International Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sandoz International Oncology Biosimilars Product and Service
-
14.8 Teva Pharmaceutical Industries Ltd
-
14.8.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.8.2 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product and Service
-
14.9 Apotex
-
14.9.1 Apotex Company Details
-
14.9.2 Apotex Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Apotex Oncology Biosimilars Product and Service
-
14.10 Biocon
-
14.10.1 Biocon Company Details
-
14.10.2 Biocon Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Biocon Oncology Biosimilars Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology Biosimilars
-
Figure Oncology Biosimilars Picture
-
Table Global Oncology Biosimilars Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Biosimilars Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology Biosimilars Consumption by Country (2017-2022)
-
Figure United States Oncology Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure China Oncology Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mAb Consumption and Growth Rate (2017-2022)
-
Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
Figure Global Hematopoietic Agents Consumption and Growth Rate (2017-2022)
-
Figure Global G-CSF Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global mAb Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematopoietic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global G-CSF Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology Biosimilars Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology Biosimilars Export by Region (Top 5 Countries) (2017-2028)
-
Table Dr Reddy’s Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy’s Laboratories Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy’s Laboratories Oncology Biosimilars Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oncology Biosimilars Product and Service
-
Table Celltrion (Foundation Year, Company Profile and etc.)
-
Table Celltrion Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Oncology Biosimilars Product and Service
-
Table BIOCAD (Foundation Year, Company Profile and etc.)
-
Table BIOCAD Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table BIOCAD Oncology Biosimilars Product and Service
-
Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Oncology Biosimilars Product and Service
-
Table STADA Arzneimittel AG (Foundation Year, Company Profile and etc.)
-
Table STADA Arzneimittel AG Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table STADA Arzneimittel AG Oncology Biosimilars Product and Service
-
Table Sandoz International (Foundation Year, Company Profile and etc.)
-
Table Sandoz International Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz International Oncology Biosimilars Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Oncology Biosimilars Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Oncology Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Oncology Biosimilars Product and Service
-
